Growth Metrics

Exact Sciences (EXAS) Current Deferred Revenue: 2009-2013

Historic Current Deferred Revenue for Exact Sciences (EXAS) over the last 5 years, with Dec 2013 value amounting to $294,000.

  • Exact Sciences' Current Deferred Revenue fell 92.90% to $294,000 in Q4 2013 from the same period last year, while for Dec 2013 it was $294,000, marking a year-over-year decrease of 92.90%. This contributed to the annual value of $294,000 for FY2013, which is 92.90% down from last year.
  • According to the latest figures from FY2013, Exact Sciences' Current Deferred Revenue is $294,000, which was down 92.90% from $4.1 million recorded in FY2012.
  • Exact Sciences' 5-year Current Deferred Revenue high stood at $11.2 million for FY2009, and its period low was $294,000 during FY2013.
  • In the last 3 years, Exact Sciences' Current Deferred Revenue had a median value of $4.1 million in 2012 and averaged $2.9 million.
  • Data for Exact Sciences' Current Deferred Revenue shows a maximum YoY plummeted of 92.90% (in 2013) over the last 5 years.
  • Over the past 5 years, Exact Sciences' Current Deferred Revenue (Yearly) stood at $11.2 million in 2009, then crashed by 62.88% to $4.1 million in 2010, then remained steady at $4.1 million in 2011, then remained steady at $4.1 million in 2012, then tumbled by 92.90% to $294,000 in 2013.